Publication | Open Access
Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin® Outcomes Registry and Experience
69
Citations
25
References
2015
Year
This study was funded by Novartis Pharma AG.
| Year | Citations | |
|---|---|---|
Page 1
Page 1